AMYLYX PHARMACEUTICALS INC (AMLX) Institutional Ownership
None of the superinvestors we track currently report AMYLYX PHARMACEUTICALS INC (AMLX) in their latest SEC Form 13F filings.
13F filings cover institutional equity holdings and are reported quarterly with a delay. This stock may still have insider Form 4 activity or appear in future filings.
When tracked funds report positions in AMYLYX PHARMACEUTICALS INC (AMLX), this page will show institutional ownership trends, hedge fund exposure, portfolio concentration, historical 13F filings, and estimated holding performance.
Institutional Ownership Trend
| Portfolio quarter | Institutional holders | Total reported value | Total shares |
|---|---|---|---|
| Q4 2025 | 1 | $2,325,400 | 192,500 |
| Q3 2025 | 1 | $270,441 | 19,900 |
| Q2 2025 | 1 | $2,539,642 | 396,200 |
| Q1 2025 | 1 | $1,823,454 | 515,100 |
| Q4 2024 | 1 | $1,755,432 | 464,400 |
| Q3 2024 | 1 | $880,632 | 271,800 |
| Q2 2024 | 1 | $1,541,827 | 811,488 |
| Q1 2024 | 1 | $2,001 | 704,600 |
| Q4 2023 | 2 | $43,609,859 | 3,033,843 |
| Q3 2023 | 2 | $54,247,130 | 3,112,655 |
| Q2 2023 | 1 | $63,902,311 | 2,962,555 |
| Q1 2023 | 1 | $86,921,364 | 2,962,555 |
Related AMLX Institutional Insights:
- AMLX Institutional Ownership & Insiders Activity
- AMLX Institutional Ownership & 13F Activity
- AMLX Top Institutional Shareholders
- AMLX Institutional Buying Activity
- AMLX Institutional Selling Activity
- Institutional Portfolio Overlap & Shared Holdings
- AMLX Insider Trading & SEC Form 4 Activity
- Top Institutional Investor Stock Rankings